F175-1019 Screening compound: 1-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]-N-[3-(1,2-oxazol-5-yl)phenyl]piperidine-4-carboxamide

F175-1019 Screening compound: 1-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]-N-[3-(1,2-oxazol-5-yl)phenyl]piperidine-4-carboxamide
F175-1019 Screening compound: 1-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]-N-[3-(1,2-oxazol-5-yl)phenyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F175-1019
1-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]-N-[3-(1,2-oxazol-5-yl)phenyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F175-1019

Molecular Formula

C25H25N5O5S (C25 H25 N5 O5 S)

Compound Name

1-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonyl]-N-[3-(1,2-oxazol-5-yl)phenyl]piperidine-4-carboxamide

IUPAC name

1-[2-methyl-5-(5-methyl-124-oxadiazol-3-yl)benzenesulfonyl]-N-[3-(12-oxazol-5-yl)phenyl]piperidine-4-carboxamide

SMILES

Cc1nc(-c2cc(S(N(CC3)CCC3C(Nc3cc(-c4ccno4)ccc3)=O)(=O)=O)c(C)cc2)no1

InChI

InChI=1S/C25H25N5O5S/c1-16-6-7-20(24-27-17(2)34-29-24)15-23(16)36(32,33)30-12-9-18(10-13-30)25(31)28-21-5-3-4-19(14-21)22-8-11-26-35-22/h3-8,11,14-15,18H,9-10,12-13H2,1-2H3,(H,28,31)

InChI Key

WRWZUKKMGGSLAS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27106854

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

507.57

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.670

Distribution Coefficient, logD

3.670

Water Solubility, LogSw

-3.77

Polar Surface Area

107.815

Acid Dissociation Constant (pKa)

13.06

Base Dissociation Constant (pKb)

0.93

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.00

F175-1019 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Kinases
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F175-1019 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F175-1019?
Check Price and Availability of F175-1019, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F175-1019 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F175-1019
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F175-1019
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F175-1019 available by request